ALOS-4 (Ariel University/Roswell Park Cancer Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALOS-4 (Ariel University/Roswell Park Cancer Institute)
Drug Alias NameALOS-4 (Ariel University/Roswell Park Comprehensive Cancer Center)cyclic peptide (Ariel University/Roswell Park Cancer Institute)ALOS-4
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAriel University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInflammationMelanoma

Other Information

ATC CodeN/A
Related LinksN/A